Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
890,865
-
Share change
-
+1,225
-
Total reported value
-
$64,249,163
-
Price per share
-
$73.82
-
Number of holders
-
87
-
Value change
-
+$102,795
-
Number of buys
-
24
-
Number of sells
-
26
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q1 2021
As of 31 Mar 2021 INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) had 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 890,865 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, ADVISOR GROUP HOLDINGS, INC., BANK OF AMERICA CORP /DE/, LPL Financial LLC, PFG Advisors, UBS Group AG, Financial Perspectives, Inc, and Anfield Capital Management, LLC.
This table shows 88 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.